Lotus Health AI key facts
as of Oct 2026- Developer of advanced healthcare analytics technology designed to improve patient outcomes through data-driven information.
- Lotus Health AI is valued at approximately $147.0M as of Oct 2026 (last reported valuation).
- It has raised $40.0M; the latest was Early Stage VC ($35.0M) in Feb 2026.
- Notable investors include Andreessen Horowitz, Sequoia Capital, Kleiner Perkins, CRV, Wormhole Capital — 13 tracked in total.
- Status: Privately Held (backing).
Lotus Health AI's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Lotus Health AI: the Monday email on marks, rounds and moves
Lotus Health AI funding rounds
No funding rounds for Lotus Health AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Lotus Health AI
13+Membership and data by Private Market View
Lotus Health AI valuation
Lotus Health AI's last reported valuation was $147 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Lotus Health AI investors
13 investors are on record for Lotus Health AI, including Andreessen Horowitz, Sequoia Capital, Kleiner Perkins and CRV. By type, the record holds 5 venture capital firms.
About Lotus Health AI
Developer of advanced healthcare analytics technology designed to improve patient outcomes through data-driven information. The company offers features such as predictive modeling, real-time health monitoring, and personalized treatment recommendations, enabling healthcare providers and organizations to improve clinical decision-making, optimize resource allocation, and deliver tailored care plans that address individual patient needs effectively.
- Sector
- Healthcare
- HQ
- Covina, CA, United States
- Founded
- 2020
- Employees
- 8
- Website
- lotus.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.